DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Q2 Results, Nov 5: Bharti Airtel, LIC, Titan, Mahindra & Mahindra, ONGC, Britannia Industries, Bharat Forge, Glenmark Pharma, others to post earnings

Upstox 20 hrs ago·5 Nov 2026, 3:07 am

Investors will get a fresh look at Britannia Industries' financial health when it reports its second-quarter results on November 5. The company is expected to disclose its revenue growth, profit margins, and the performance of its key product categories during this period.

This earnings report is significant for shareholders as it provides insight into the company's ability to navigate a competitive market. It will also offer clues on consumer demand trends and the effectiveness of its current business strategies.

Moving forward, market participants will focus on the management commentary regarding future growth prospects and any updates on operational efficiency. Keeping an eye on the quarterly sales figures will be crucial for assessing the stock's near-term performance.